Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Acute Human Parvovirus B19 Infection: Cytologic Diagnosis

Authors: Rane Sharada Raju, Kadgi Nalini Vinayak, Vishnuprasad Madhusudan Bapat, Agrawal Preeti Balkisanji, Puranik Shaila Chandrakant

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Human parvovirus B19 is highly tropic to human bone marrow and replicates only in erythroid progenitor cells. It is causative agent of transient aplastic crisis in patients with chronic haemolytic anemia. In immunocompromised patients persistent parvovirus B19 infection may develop and it manifests as pure red cell aplasia and chronic anaemia. Bone marrow is characterised morphologically by giant pronormoblast stage with little or no further maturation. We encountered a case of 6 year old HIV positive male child presented with pure red cell aplasia due to parvovirus B19 infection. Bone marrow aspiration cytology revealed giant pronormoblast with prominent intranuclear inclusions led to suspicion of parvovirus B19 infection which was confirmed by DNA PCR. This case is presented to report classical morphological features of parvovirus B19 infection rarely seen on bone marrow examination should warrant the suspicion of human parvovirus B19 infection in the setting of HIV positive patient with repeated transfusions and confirmation should be done by PCR.
Literature
1.
2.
go back to reference Cossart YE, Field AM, Cant B, Widdow D (1975) Parvovirus like particles in human sera. Lancet 1(7898):72–73PubMedCrossRef Cossart YE, Field AM, Cant B, Widdow D (1975) Parvovirus like particles in human sera. Lancet 1(7898):72–73PubMedCrossRef
3.
go back to reference Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMedCrossRef Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117PubMedCrossRef
4.
go back to reference Wan Z, Zhi N, Wong S, Keyvanfar K, Liu D, Raghavachari N, Munson P, Su S, Malide D, Kajigaya S, Young N (2010) Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 120(10):3530–3544PubMedCrossRefPubMedCentral Wan Z, Zhi N, Wong S, Keyvanfar K, Liu D, Raghavachari N, Munson P, Su S, Malide D, Kajigaya S, Young N (2010) Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 120(10):3530–3544PubMedCrossRefPubMedCentral
5.
go back to reference Galel SA, Malone JM, Vivele MK.Transfusion Medicine. In: Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B.Wintrobe′s clinical hematology. 11th ed. Philadelphia:Lippincott Williams & Wilkins;2004. p.869-870 Galel SA, Malone JM, Vivele MK.Transfusion Medicine. In: Greer JP, Rodgers GM, Foerster J, Paraskevas F, Lukens JN, Glader B.Wintrobe′s clinical hematology. 11th ed. Philadelphia:Lippincott Williams & Wilkins;2004. p.869-870
7.
go back to reference Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS (1997) Clinical relevance of parvovirus B19 as a cause of anemia in patients with Human Immunodeficiency virus infection. J Infect Dis 176:269–273PubMedCrossRef Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS (1997) Clinical relevance of parvovirus B19 as a cause of anemia in patients with Human Immunodeficiency virus infection. J Infect Dis 176:269–273PubMedCrossRef
Metadata
Title
Acute Human Parvovirus B19 Infection: Cytologic Diagnosis
Authors
Rane Sharada Raju
Kadgi Nalini Vinayak
Vishnuprasad Madhusudan Bapat
Agrawal Preeti Balkisanji
Puranik Shaila Chandrakant
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0287-7

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine